HIINX
Price
$54.01
Change
-$0.75 (-1.37%)
Updated
Aug 25 closing price
Net Assets
3.8B
VTISX
Price
$162.01
Change
-$1.46 (-0.89%)
Updated
Aug 25 closing price
Net Assets
505.75B
Interact to see
Advertisement

HIINX vs VTISX

Header iconHIINX vs VTISX Comparison
Open Charts HIINX vs VTISXBanner chart's image
Harbor International Investor
Price$54.01
Change-$0.75 (-1.37%)
VolumeN/A
Net Assets3.8B
Vanguard Total Intl Stock Idx Instl Sel
Price$162.01
Change-$1.46 (-0.89%)
VolumeN/A
Net Assets505.75B
HIINX vs VTISX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HIINX vs. VTISX commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIINX is a Buy and VTISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 506B vs. HIINX (3.8B). HIINX (2.94) and VTISX (2.87) have matching dividends . HIINX was incepted earlier than VTISX: HIINX (23 years) vs VTISX (9 years). HIINX (1.24) is less costly to investors than VTISX (0.05). HIINX is a more actively managed with annual turnover of: 32.00 vs. VTISX (3.00). HIINX has a lower initial minimum investment than VTISX: HIINX (2500) vs VTISX (3000000000). HIINX (15.10) and VTISX (15.09) have marching annual gain over last year. HIINX return over 5 years is better than : 54.78 vs. VTISX (39.34).
HIINXVTISXHIINX / VTISX
Total Expense Ratio1.150.052,447%
Annual Report Gross Expense Ratio1.240.052,638%
Fund Existence23 years9 years-
Gain YTD23.03022.804101%
Front LoadN/AN/A-
Min. Initial Investment250030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.8B506B1%
Annual Yield % from dividends2.942.87102%
Returns for 1 year15.1015.09100%
Returns for 3 years53.7442.90125%
Returns for 5 years54.7839.34139%
Returns for 10 years-5.05N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMCB1.020.05
+5.66%
PharmaCyte Biotech
RAPP14.63-0.14
-0.95%
Rapport Therapeutics Inc.
GMAB24.31-0.34
-1.38%
Genmab A/S ADS
PAYO6.78-0.23
-3.28%
Payoneer Global
CSBR7.06-0.57
-7.47%
Champions Oncology